The UK has so far secured access to 367m doses from seven vaccine developers

Oxford/

AstraZeneca

BioNTech/

Pfizer

Moderna

100m

40m

17m

Approved and

in deployment

Approved and

in deployment

Approved

GSK/Sanofi

Pasteur

Novavax

Janssen

Valneva

60m

30m

60m

60m

Phase 3

trials

Phase 3

trials

Phase 1/2

trials

Phase 1/2

trials

Oxford/

AstraZeneca

BioNTech/

Pfizer

GSK/

Sanofi Pasteur

Moderna

Novavax

Janssen

Valneva

100m

40m

17m

60m

30m

60m

60m

Approved and

in deployment

Approved and

in deployment

Approved

Phase 3

trials

Phase 3

trials

Phase 1/2

trials

Phase 1/2

trials